|
| 产品描述 |
| LY2922470 is a Potent and Selective GPR40 Agonist for the Treatment of Type 2 Diabetes Mellitus. LY2922470 demonstrated potent, efficacious and durable dose dependent reductions in glucose levels along with significant increases in insulin and GLP-1 secretion during preclinical testing. The G protein-coupled receptor 40 (GPR40) also known as Free Fatty Acid Receptor 1 (FFAR1) is highly expressed in pancreatic, islet beta-cells and responds to endogenous fatty acids resulting in amplification of insulin secretion only in the presence of elevated glucose levels. |
| 化学结构 |
 |
| 化学名称 |
| (S)-3-(4-((5-((8-methoxy-3,4-dihydroquinolin-1(2H)-yl)methyl)thiophen-2-yl)methoxy)phenyl)hex-4-ynoic acid |
| SMILES Code |
| O=C(C[C@@H](C1=CC=C(OCC2=CC=C(CN3CCCC4=C3C(OC)=CC=C4)S2)C=C1)C#CC)O |
| 基本信息 |
产品编号:XM346
产品名称:LY2922470
别名:LY2922470; LY-2922470; LY 2922470.
CAS#:1423018-12-5
分子式:C28H29NO4S
精确分子量:475.1817
分子量:475.603
|
| 物化性质 |
外观: 白色或类白色固体粉末
纯度: >98%
运输信息: 非危险化学品，适于常温或冰袋运输。
储存条件: 低温，干燥，避光。
溶解性: 溶于DMSO, 不溶于水
储存期限:3年 -20℃固体储存
2 年 -80℃ 溶液储存 |
该产品只供科研使用，不能给病人提供。
|
|
|
